214 results on '"Huy N. Trinh"'
Search Results
152. Long-Term Treatment Outcome of Entecavir (ETV) Monotherapy in Treatment-Naive Hepatitis B e Antigen-positive Chronic Hepatitis B (CHB) Patients in a Real-Life Setting
153. How Many Patients with Chronic Hepatitis B (CHB) Seen at a U.S. Gastroenterology Clinic Would Be Eligible for Antiviral Therapy?
154. Long-Term Outcome of Chronic Hepatitis B Patients Initially Treated with Adefovir Dipivoxil in a Community Practice
155. Outcomes of Screening Colonoscopy in Asian Americans Compared to Other Ethnic Groups
156. Outcomes of Colonoscopic Evaluation for Rectal Bleeding in Asian Americans
157. Sa1005 Antiviral Treatment Eligibility and Treatment Rates in Patients With Chronic Hepatitis B (CHB) At Primary Care, Community and University Referral Clinics: A Comparative Study
158. Su1286 Differences Between Community and Academic Cohorts of Patients With Chronic Hepatitis B (CHB) in the Development of Hepatocellular Carcinoma (HCC)
159. Sa1009 Tenofovir Is More Effective Than Entecavir for Achieving Rapid Viral Suppression in HBeAg-Positive Chronic Hepatitis B Patients With High HBV DNA Levels
160. Sa1006 Effectiveness of Oral Antiviral Therapy for Treatment-Naive Chronic Hepatitis B (CHB) in Routine Clinical Practice
161. Maintenance of Complete Viral Suppression (CVS) with Tenofovir (TDF) Monotherapy Following CVS with Entecavir (ETV)+TDF Combination in Patients with Prior ETV Partial Response
162. Sa1087 Less Established Risk Factors are Common in Asian Americans With Hepatitis C Virus: A Case-Control Study
163. 465 Renal Dysfunction in Chronic Hepatitis B (CHB) Patients Treated With Tenofovir Dipivoxil Fumarate (TDF) Monotherapy
164. Mo1893 Evaluation of Treatment-Eligibility for Antiviral Therapy During Follow-up in Chronic Hepatitis B Patients Initially Ineligible for Treatment
165. Mo1896 Chronic Hepatitis B (CHB) Treatment Eligibility and Actual Treatment Rates at Community Gastroenterology Clinics and Primary Care Clinics
166. Mo1902 Hepatitis B Surface Antigen (HBsAg) Seroclearance Rate in a Multicenter U.S. Cohort Study
167. Sa1043 Outcomes of Oral Antiviral Treatment for Chronic Hepatitis B (CHB) in Routine Clinical Practice
168. Mo1904 Treatment Evaluation of Chronic Hepatitis B (CHB) Patients at Tertiary Care and Community Centers
169. Sa1003 High Prevalence of Hepatitis C Virus in Ethnically Diverse Community Patients With Non-Liver Related Gastrointestinal Complaints
170. 467 Maintenance of Complete Viral Suppression (CVS) With Tenofovir (TDF) Monotherapy in Patients With Prior Partial Response to Entecavir (ETV) Who Have Achieved CVS With ETV+TDF Combination Therapy
171. Su2044 Incidence of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients With Chronic Hepatitis B (CHB): Results of a Multicenter Cohort Study
172. Adefovir (ADV) Partial Response in Patients with Chronic Hepatitis B (CHB): Switch Versus Add-On Therapy
173. Risk Factors for Hepatitis C Virus (HCV) Infection in Asian American Patients: A Case-Control Study
174. Treatment of Chronic Hepatitis B Patients According to Current Guidelines: A Community-Based Study
175. Proportion of Patients Who Were Previously Ineligible for Anti-HBV Therapy Who Became Eligible After 12 Months of Follow-up: Application of U.S. Panel and AASLD Guidelines
176. HBV Precore C1858T Mutation Does Not Share Similar Clinical or Virologic Characteristics With Other Precore Mutants
177. Tenofovir Disoproxil Fumarate (TDF) Shows Similar Virologic Suppression and Safety Between Asians and Non-Asians With Chronic Hepatitis B (CHB)
178. Rapid Complete Viral Suppression (CVS) With Entecavir (ETV) in Adefovir (ADV)-Experienced Patients: Interim Report for a Multicenter Study
179. Incidence of Hepatitis B E Antigen (HBeAg) Seroconversion and Suboptimal Response in Chronic Hepatitis B (CHB) Patients Treated With Entecavir 0.5 mg Daily in Routine Clinical Practice
180. Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies
181. Hepatitis B Virus (HBV) Reverse Transcriptase Mutation Prevalence Was Low in Treatment-NaïVE Patients With Chronic Hepatitis B (CHB) Using Inno-Lipa HBV DR3 in a Prospective Multicenter Study
182. High Rate of Recurrent Hepatitis B Viremia Following Treatment-Induced Hepatitis B E Antigen (HBeAg) Seroconversion
183. Long-Term Treatment Response to Entecavir and Adefovir in Treatment-NaïVE Chronic Hepatitis B E Antigen-Negative Patients in a Community Setting
184. Virologic Relapse following Treatment Induced Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B (CHB) Patients
185. 314 Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaïVE Chronic Hepatitis C Genotype 6
186. W1011 Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B (CHB) Infection in Vietnamese Americans in California: A Prospective Study
187. 80 Hepatocellular Carcinoma Incidence in a Cohort of 981 U.S. Patients With Chronic Hepatitis B Without Cirrhosis and Patients With Cirrhosis of All Etiologies
188. M1892 Hepatitis B-E Antigen Positive (HBeAg+) Chronic Hepatitis B (CHB) Patients With Precore (PC) and Basic Core Promoter (BCP) Mutations
189. 636 High Rate of Complete Viral Suppression With Combination Therapy With Tenofovir Using Entecavir or Lamivudine/Emtricitabine in Patients With Chronic Hepatitis B and Prior Monotherapy Failure
190. M1893 Hepatitis B Virus Reverse Transcriptase Mutations Were Not Detected in Treatment-NaïVE Patients With Chronic Hepatitis B Using Inno Lipa HBV DR3: A Prospective Multicenter Study
191. M1903 Long-Term Outcome of Treatment-NaïVE Chronic Hepatitis B (CHB) E Antigen-Negative Treated With Entecavir 0.5 Mg (ETV) or Adefovir 10 Mg (ADV) in a Real-Life Community Setting
192. T1967 Asian Ethnicity is a Significant Predictor for Viral Dominance by HBV in HBV/HCV Co-Infected Patients: A Multicenter, Matched Case-Control Study
193. 634 Treatment Efficacy of Entecavir (ETV) Therapy in Patients Previously Treated With Adefovir (ADV): Interim Report for a Multicenter Study
194. Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B (CHB) Infection in Vietnamese Americans in the San Francisco Bay Area, California: A Cross-Sectional Study
195. W1809 Changes in Creatinine Clearance (CrCl) in Chronic Hepatitis B (CHB) Patients Treated with Adefovir Dipivoxil (ADV): A Case-Control Study
196. 322 Tenofovir Disoproxil Fumarate (TDF) Versus Emtricitabine Plus TDF (FTC/TDF) for Treatment of Chronic Hepatitis B (CHB) in Patients with Persistent Viral Replication Receiving Adefovir Dipivoxil
197. W1807 Long-Term Outcome of Chronic Hepatitis B Patients Initially Treated with Entecavir in a Real-Life Clinical Setting
198. M1777 Poor Adherence to Screening for Hepatocellular Carcinoma (HCC), Especially in Patients with Chronic Hepatitis B (CHB) Without Cirrhosis Compared to Patients with Cirrhosis of All Etiologies
199. 11 Treatment Response and Tolerability to Pegylated Interferon (PEG Inf) and Ribavirin (RBV) in Treatment-Naïve Asian American Patients with Chronic Hepatitis C and Genotype 1, 2/3 and 6
200. 319 Response to Entecavir (ETV) in Patients with Chronic Hepatitis B (CHB) and Prior Suboptimal Response to Adefovir (ADV): Interim Report of a Multicenter Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.